Loading the company…
Loading the company…
Families: Sleep apnea & airway implants.
All companies · Product and company coverage
In the last ten years FDA made 118 decisions for Inspire Medical Systems (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2020 (16). The latest was on 2026-10-13.
| Family | Decisions on record |
|---|---|
| Sleep apnea & airway implants | 136 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-10-13 | PMA | P130008-S146 | Model 3150 IPG · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-08-28 | PMA | P130008-S123 | INSPIRE II UPPER AIRWAY STIMULATOR · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-08-28 | PMA | P130008-S136 | Model 4063 Inspire Stimulation Lead · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-08-17 | PMA | P130008-S143 | Inspire Upper Airway Stimulation (UAS) System · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
In 2025, Inspire Medical Systems reported engagement with 24,599 surgeons and other clinicians in the states MedaRep covers, worth $4.9M in consulting, speaking, meals and travel for its device products, the most in Texas ($568K to 3,477). Royalties are left out.
| 2026-08-11 | PMA | P130008-S142 | Model 4063 Inspire Stimulation Lead · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Inspire Medical Systems.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Texas ($568K, 3,477 engaged), Florida ($400K, 1,445 engaged), California ($355K, 1,275 engaged), Virginia ($280K, 770 engaged), Arizona ($263K, 875 engaged).